US FDA Neuroscience Office Director Billy Dunn Departs As Agency Faces New Review Challenges

 
• By Sue Sutter
Door handle
FDA's Billy Dunn is closing the door on an 18-year career at the agency. • Source: Shutterstock

More from US FDA

More from Agency Leadership